寒武纪(688256) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the first nine months was ¥157,529,957.92, up 42.97% from ¥110,185,776.26 in the same period last year[5]. - Net profit attributable to shareholders was -¥309,512,213.85, an improvement from -¥585,820,052.77 in the previous year[5]. - The weighted average return on net assets increased by 17.29 percentage points to -6.51%[5]. - Basic and diluted earnings per share were both -¥0.84, with no applicable data for the previous year[7]. - The company reported a net loss of CNY -1,164,149,257.71 for the period, worsening from a loss of CNY -854,637,043.86 in the previous year[21]. - The company anticipates continued losses until the end of the next reporting period, primarily due to ongoing large-scale R&D investments[16]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥6,955,822,478.64, a 49.00% increase compared to the end of the previous year[5]. - Net assets attributable to shareholders of the listed company were ¥6,546,116,245.27, reflecting a 50.26% increase year-on-year[5]. - The company's total liabilities increased to ¥409,706,233.37 from ¥311,992,772.79 year-on-year, reflecting the expansion of operations[66]. - Total current liabilities decreased to CNY 117,112,116.03 from CNY 237,975,074.96, a reduction of 50.8%[20]. - The total capital reserve increased by 50.69% to RMB 7,310,165,502.98 from RMB 4,851,116,552.63, driven by the public issuance of shares[13]. Cash Flow - Cash flow from operating activities for the first nine months was -¥316,849,416.33, compared to -¥270,600,805.22 in the same period last year[5]. - The company reported a net cash flow from operating activities of RMB -316,849,416.33, compared to RMB -270,600,805.22 in the previous year, attributed to increased operational expenses[15]. - Cash inflow from investment activities reached approximately ¥11.77 billion, up from ¥5.64 billion in 2019, marking an increase of 108.5%[85]. - The net cash flow from financing activities for the first three quarters of 2020 was approximately ¥2.49 billion, up from ¥1.70 billion in 2019, reflecting a growth of 46.5%[83]. Research and Development - Research and development expenses accounted for 274.98% of operating revenue, a decrease of 21.09 percentage points compared to the previous year[7]. - Research and development expenses rose by 32.78% to RMB 433,183,542.09 from RMB 326,230,271.38, reflecting the company's commitment to increasing R&D investment[15]. - Research and development expenses for Q3 2020 amounted to ¥155,791,355.24, a decrease of 19.5% compared to ¥193,544,238.44 in Q3 2019[26]. Shareholder Information - The company reported a total of 25,117 shareholders at the end of the reporting period[10]. - The top shareholder, Chen Tian Shi, holds 29.87% of the shares, totaling 119,497,756 shares[10]. Inventory and Accounts Receivable - Accounts receivable increased by 103.79% to RMB 131,667,081.92 from RMB 64,608,654.82 year-over-year, primarily due to increased sales[13]. - Inventory increased to CNY 75,619,580.29, up from CNY 51,065,453.41, reflecting a growth of 48.0%[20]. Comprehensive Income - The company reported a total comprehensive loss of ¥107,652,657.23 for Q3 2020, compared to a loss of ¥555,020,022.19 in Q3 2019, marking a 80.7% reduction[29]. - The total comprehensive income attributable to the parent company's shareholders for Q3 2020 was -¥107,652,657.23, compared to -¥555,019,670.94 in Q3 2019, indicating a 80.7% improvement[76].